1
|
Hong WM, Xie YW, Zhao MY, Yu TH, Wang LN, Xu WY, Gao S, Cai HB, Guo Y, Zhang F. Vasoprotective Effects of Hyperoside against Cerebral Ischemia/Reperfusion Injury in Rats: Activation of Large-Conductance Ca 2+-Activated K + Channels. Neural Plast 2023; 2023:5545205. [PMID: 37609123 PMCID: PMC10442186 DOI: 10.1155/2023/5545205] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2022] [Revised: 06/29/2023] [Accepted: 07/19/2023] [Indexed: 08/24/2023] Open
Abstract
Hyperoside (Hyp), a kind of Chinese herbal medicine, exerts multiple therapeutic effects on many diseases. However, the role and mechanisms of Hyp in vascular pathophysiology in ischemic stroke need to be further established. The study aimed to investigate the role of (large-conductance Ca2+-activated K+) BK channels on the vasoprotection of Hyp against cerebral ischemia and reperfusion (I/R) injury in rats. The concentration gradient of Hyp was pretreated in both the middle cerebral artery occlusion and reperfusion model and oxygen-glucose deprivation/reoxygenation (OGD/R) model of primary vascular smooth muscle cells (VSMCs) in rats. A series of indicators were detected, including neurological deficit score, infarct volume, malondialdehyde (MDA), superoxide dismutase (SOD), cerebral blood flow (CBF), cell viability, membrane potential, and BK channels α- and β1-subunits expression. The results showed that Hyp significantly reduced infarct volume and ameliorated neurological dysfunction in I/R-injured rats. Besides, the effects of I/R-induced reduction of BK channels α- and β1-subunits expression were significantly reversed by Hyp in endothelial-denudated cerebral basilar arteries. Furthermore, the protective effect against I/R-induced increases of MDA and reduction of SOD as well as CBF induced by Hyp was significantly reversed by iberiotoxin (IbTX). In OGD/R-injured VSMCs, downregulated cellular viability and BK channels β1-subunits expression were remarkably reversed by Hyp. However, neither OGD/R nor Hyp affected BK channels α-subunits expression, and Hyp failed to induced hyperpolarization of VSMCs. Moreover, the protective effect against OGD/R-induced reduction of cell viability and SOD level and increases of MDA production induced by Hyp was significantly reversed by IbTX in VSMCs. The study indicates that Hyp has the therapeutic potential to improve vascular outcomes, and the mechanism is associated with suppressing oxidative stress and improving CBF through upregulating BK channels.
Collapse
Affiliation(s)
- Wen-Ming Hong
- Department of Neurosurgery, First Affiliated Hospital of Anhui Medical University, Hefei 230032, China
- School of Nursing, Anhui Medical University, Hefei 230032, China
- Open Project of Key Laboratory of Dermatology, Ministry of Education, Anhui Medical University, Hefei 230032, China
| | - Yue-Wu Xie
- School of Pharmacy, Wannan Medical College, Wuhu 241002, China
| | - Meng-Yu Zhao
- Department of Neurosurgery, First Affiliated Hospital of Anhui Medical University, Hefei 230032, China
| | - Tian-Hang Yu
- Department of Neurosurgery, First Affiliated Hospital of Anhui Medical University, Hefei 230032, China
| | - Li-Na Wang
- School of Nursing, Anhui Medical University, Hefei 230032, China
| | - Wan-Yan Xu
- School of Nursing, Anhui Medical University, Hefei 230032, China
| | - Shen Gao
- Department of Neurosurgery, First Affiliated Hospital of Anhui Medical University, Hefei 230032, China
| | - Hua-Bao Cai
- Department of Neurosurgery, First Affiliated Hospital of Anhui Medical University, Hefei 230032, China
| | - Yan Guo
- Department of Pharmacology, Anhui Medical University, Hefei 230032, China
| | - Fang Zhang
- School of Nursing, Anhui Medical University, Hefei 230032, China
| |
Collapse
|
2
|
Xia J, Wan Y, Wu JJ, Yang Y, Xu JF, Zhang L, Liu D, Chen L, Tang F, Ao H, Peng C. Therapeutic potential of dietary flavonoid hyperoside against non-communicable diseases: targeting underlying properties of diseases. Crit Rev Food Sci Nutr 2022; 64:1340-1370. [PMID: 36073729 DOI: 10.1080/10408398.2022.2115457] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Non-communicable diseases (NCDs) are a global epidemic with diverse pathogenesis. Among them, oxidative stress and inflammation are the most fundamental co-morbid features. Therefore, multi-targets and multi-pathways therapies with significant anti-oxidant and anti-inflammatory activities are potential effective measures for preventing and treating NCDs. The flavonol glycoside compound hyperoside (Hyp) is widely found in a variety of fruits, vegetables, beverages, and medicinal plants and has various health benefits, especially excellent anti-oxidant and anti-inflammatory properties targeting nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor-κB (NF-κB) signaling pathways. In this review, we summarize the pathogenesis associated with oxidative stress and inflammation in NCDs and the biological activity and therapeutic potential of Hyp. Our findings reveal that the anti-oxidant and anti-inflammatory activities regulated by Hyp are associated with numerous biological mechanisms, including positive regulation of mitochondrial function, apoptosis, autophagy, and higher-level biological damage activities. Hyp is thought to be beneficial against organ injuries, cancer, depression, diabetes, and osteoporosis, and is a potent anti-NCDs agent. Additionally, the sources, bioavailability, pharmacy, and safety of Hyp have been established, highlighting the potential to develop Hyp into dietary supplements and nutraceuticals.
Collapse
Affiliation(s)
- Jia Xia
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yan Wan
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jiao-Jiao Wu
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yu Yang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jin-Feng Xu
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Li Zhang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Dong Liu
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Lu Chen
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Fei Tang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Hui Ao
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
- Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Cheng Peng
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| |
Collapse
|
3
|
Tan J, Li X, Zhu Y, Sullivan MA, Deng B, Zhai X, Lu Y. Antidepressant Shugan Jieyu Capsule Alters Gut Microbiota and Intestinal Microbiome Function in Rats With Chronic Unpredictable Mild Stress -Induced Depression. Front Pharmacol 2022; 13:828595. [PMID: 35770090 PMCID: PMC9234866 DOI: 10.3389/fphar.2022.828595] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Accepted: 05/30/2022] [Indexed: 12/12/2022] Open
Abstract
Shugan Jieyu Capsule (SG) has been widely used in China to treat mild to moderate depression. Hypericum perforatum L. (St John’s Wort, SJW) is the main ingredient of SG and has been used as herbal medicine to treat depression in western countries. However, it is known that SJW has low bioavailability and does not easily get through the blood-brain barrier. Therefore, how SG plays an antidepressant effect in the central nervous system (CNS) remains an urgent problem to be solved. Mounting research has described the relationship between antidepressants and intestinal microbiota to illuminate antidepressive mechanisms in the CNS. We aimed to investigate the effects of therapy with SG on the function of gut microbiota and intestinal microbiota in rats with chronic unpredictable mild stress (CUMS)-induced depression. The psychophysiological state and the hypothalamic-pituitary-adrenal axis function of rats are evaluated through behavioral experiments, corticosterone levels, serotonin levels, and adrenal index measurements. 16S rDNA amplicon sequencing is used to test the changes in gut microbiota and make functional predictions of genes. With treatment of SG, the depression-like behaviors of CUMS-induced rats were reversed; the corticosterone levels and the adrenal index decreased significantly; the level of serotonin increased significantly; and the alpha and beta diversity analysis of microbiota showed an increase in the richness and uniformity of the flora were increased. SG regulated the relative abundance of Actinobacteria, Erysipelotrichaceae, Bifidobacteriaceae, Atopobiaceae, Dubosiella, and Bifidobacterium; Linear discriminant analysis effect size analysis demonstrated that Lactobacillaceae (family level), Lactobacillus (genus level), Lactobacillales (order level), Bacilli (class level), and Lactobacillus-reuteri (species level) were biomarkers in the SG group samples, and also likely to modulate metabolic pathways, such as those involved in carbohydrate metabolism, amino acid metabolism, and signal transduction. These data clearly illustrated the effect of SG on gut microbiome, thus laying the foundation for uncovering more insights on the therapeutic function of the traditional Chinese antidepressants. The potential of SG on mechanisms of antidepression to alter gut microbiota and intestinal microbiome function exposed to CUMS can be explored.
Collapse
Affiliation(s)
- Jingxuan Tan
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Xixuan Li
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Ying Zhu
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Mitchell A. Sullivan
- Glycation and Diabetes Group, Mater Research Institute- University of Queensland, The Translational Research Institute, Brisbane, QLD, Australia
| | - Bin Deng
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Hubei Clinical Research Centre of Precision Drug Use for Major Diseases, Wuhan, China
| | - Xuejia Zhai
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Hubei Clinical Research Centre of Precision Drug Use for Major Diseases, Wuhan, China
- *Correspondence: Xuejia Zhai, ; Yongning Lu,
| | - Yongning Lu
- Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- Hubei Clinical Research Centre of Precision Drug Use for Major Diseases, Wuhan, China
- *Correspondence: Xuejia Zhai, ; Yongning Lu,
| |
Collapse
|
4
|
Yuan W, Wang J, An X, Dai M, Jiang Z, Zhang L, Yu S, Huang X. UPLC-MS/MS Method for the Determination of Hyperoside and Application to Pharmacokinetics Study in Rat After Different Administration Routes. Chromatographia 2021; 84:249-256. [PMID: 33487663 PMCID: PMC7810192 DOI: 10.1007/s10337-020-04002-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2020] [Revised: 12/08/2020] [Accepted: 12/30/2020] [Indexed: 12/14/2022]
Abstract
A rapid and sensitive UPLC-MS/MS method was developed and fully validated for the quantification of hyperoside in rat plasma after intragastric, intraperitoneal and intravenous administration. Geniposide was used as an internal standard, and simple liquid–liquid extraction by ethyl acetate was utilized for to extracting the analytes from the rat plasma samples. Chromatographic separation was carried out on an InfinityLab Poroshell 120EC-C18column (2.1 mm × 50 mm, 1.9-Micro, Agilent technologies, USA). The mobile phase consisted of methanol (A) and water (B) (containing 0.1% acetic acid) at a flow rate of 0.4 mL/min. A run time of 3 min for each sample made it possible to analyze more than 300 plasma samples per day. The validated linear ranges of hyperoside were 2–1000 ng/mL in rat plasma. The intra-day and inter-day precision were within 2.6–9.3%, and accuracy were ± 8.6%. And the results of recovery and matrix interference studies were well within the accepted variability limits. Finally, this method was fully validated and successfully applied to the pharmacokinetic studies of hyperoside via different administration routes in rats.
Collapse
Affiliation(s)
- Wenjing Yuan
- Institute of Pharmaceutical Research, New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009 People's Republic of China
| | - Jingjing Wang
- Institute of Pharmaceutical Research, New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009 People's Republic of China
| | - Xiaofei An
- Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210009 People's Republic of China
| | - Mingxin Dai
- Institute of Pharmaceutical Research, New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009 People's Republic of China
| | - Zhenzhou Jiang
- Institute of Pharmaceutical Research, New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009 People's Republic of China
| | - Luyong Zhang
- Institute of Pharmaceutical Research, New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Center for Drug Screening and Pharmacodynamics Evaluation, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006 People's Republic of China
| | - Sen Yu
- Mosim Co., Ltd, Nanjing, 210009 People's Republic of China
| | - Xin Huang
- Institute of Pharmaceutical Research, New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009 People's Republic of China.,National Nanjing Center for Drug Screening, China Pharmaceutical University, Nanjing, 210009 People's Republic of China
| |
Collapse
|
5
|
Luan F, Wu Q, Yang Y, Lv H, Liu D, Gan Z, Zeng N. Traditional Uses, Chemical Constituents, Biological Properties, Clinical Settings, and Toxicities of Abelmoschus manihot L.: A Comprehensive Review. Front Pharmacol 2020; 11:1068. [PMID: 32973492 PMCID: PMC7482509 DOI: 10.3389/fphar.2020.01068] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2019] [Accepted: 06/30/2020] [Indexed: 12/14/2022] Open
Abstract
Abelmoschus manihot, an annual herbal flowering plant, is widely distributed throughout eastern Europe and in temperate and subtropical regions of Asia. Its flowers have been traditionally used for the treatment of chronic kidney disease in China. Currently, more than 128 phytochemical ingredients have been obtained and identified from the flowers, seeds, stems, and leaves of A. manihot. The primary components are flavonoids, amino acids, nucleosides, polysaccharides, organic acids, steroids, and volatile oils. A. manihot and its bioactive constituents possess a plethora of biological properties, including antidiabetic nephropathy, antioxidant, antiadipogenic, anti-inflammatory, analgesic, anticonvulsant, antidepressant, antiviral, antitumor, cardioprotective, antiplatelet, neuroprotective, immunomodulatory, and hepatoprotective activities, and have effects on cerebral infarction, bone loss, etc. However, insufficient utilization and excessive waste have already led to a rapid reduction of resources, meaning that a study on the sustainable use of A. manihot is urgent and necessary. Moreover, the major biologically active constituents and the mechanisms of action of the flowers have yet to be elucidated. The present paper provides an early and comprehensive review of the traditional uses, chemical constituents, pharmacological activities, and pharmaceutical, quality control, toxicological, and clinical settings to emphasize the benefits of this plant and lays a solid foundation for further development of A. manihot.
Collapse
Affiliation(s)
- Fei Luan
- Department of Clinical Pharmacy, Shaanxi Provincial Hospital of Tuberculosis Prevention and Treatment, Xi'an, China.,Department of Pharmacology, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Qianhong Wu
- Department of Clinical Pharmacy, Shaanxi Provincial Hospital of Tuberculosis Prevention and Treatment, Xi'an, China
| | - Yan Yang
- Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China
| | - Haizhen Lv
- Department of Clinical Pharmacy, Shaanxi Provincial Hospital of Tuberculosis Prevention and Treatment, Xi'an, China
| | - Daoheng Liu
- Department of Clinical Pharmacy, Shaanxi Provincial Hospital of Tuberculosis Prevention and Treatment, Xi'an, China
| | - Zhaoping Gan
- Department of Clinical Pharmacy, Shaanxi Provincial Hospital of Tuberculosis Prevention and Treatment, Xi'an, China
| | - Nan Zeng
- Department of Pharmacology, College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
| |
Collapse
|
6
|
Lu D, Xu X, Li C, Wang S. Liquid chromatography coupled with hybrid ion trap time-of-flight mass spectrometry method for the determination of caulophine in rat bio-samples and its pharmacokinetic study after intragastric and intraperitoneal administration. J Sep Sci 2017; 41:422-431. [DOI: 10.1002/jssc.201700846] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2017] [Revised: 10/10/2017] [Accepted: 10/16/2017] [Indexed: 11/11/2022]
Affiliation(s)
- Dan Lu
- School of Pharmacy; Xi'an Jiaotong University; Xi'an China
| | - Xiao Xu
- School of Pharmacy; Xi'an Jiaotong University; Xi'an China
- Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis; Xi'an China
| | - Chunlei Li
- Department of Pharmacy; Affiliated Dongfeng Hospital; Hubei University of Medicine; Shiyan China
| | - Sicen Wang
- School of Pharmacy; Xi'an Jiaotong University; Xi'an China
- Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis; Xi'an China
| |
Collapse
|
7
|
Wang J, Wei Y, Fei YR, Fang L, Zheng HS, Mu CF, Li FZ, Zhang YS. Preparation of mixed monoterpenes edge activated PEGylated transfersomes to improve the in vivo transdermal delivery efficiency of sinomenine hydrochloride. Int J Pharm 2017; 533:266-274. [PMID: 28943208 DOI: 10.1016/j.ijpharm.2017.09.059] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2017] [Revised: 09/07/2017] [Accepted: 09/20/2017] [Indexed: 11/26/2022]
Abstract
Surfactants generally have been used as edge activators of transfersomes. However, surfactants edge activated transfersomes frequently lead to cutaneous irritation, skin lipid loss and other side effects after dermal administration. In this study, mixed monoterpenes edge activated PEGylated transfersomes (MMPTs) were prepared by ethanol injection process with sinomenine hydrochloride as a model drug. The formulation of MMPTs was optimized by an orthogonal design. We investigated skin permeation/deposition characteristics and pharmacokinetics of sinomenine hydrochloride loaded in MMPTs by comparing with liposomes using in vitro skin tests and in vivo cutaneous microdialysis. In in vitro study, the accumulative skin permeated quantity (ASPQ) and skin permeation rate (SPR) of simonenine (SIN) in the optimized MMPTs were prominently higher than that in the other MMPTs. The optimized MMPTs had a SIN ASPQ of over three times of SIN ASPQ in the liposomes and much larger SPR of SIN compared with the latter. In contrast, the drug deposition of the optimized MMPTs in the stratum corneum was much less than that of the conventional liposomes. It was noteworthy that the drug deposition curve in the whole skin (stratum corneum-stripped skin, either) for the optimized MMPTs increased initially and then decreased with an obvious peak deposition amount at 12h, while, a relatively steady curve was observed for the liposomes. In in vivo cutaneous pharmacokinetic study, the steady state concentration (Css) and the area under the curve (AUC0→t) of SIN from the optimized MMPTs was 8.7 and 8.2 folds higher than those from the liposomes, respectively. Moreover, the MRT0-inf of SIN from optimal MMPTs got shorter than that from the liposomes. It can be concluded that the optimized MMPTs obviously enhance the percutaneous absorption of sinomenine.
Collapse
Affiliation(s)
- Juan Wang
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 311402, China
| | - Yan Wei
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 311402, China
| | - Ya-Rong Fei
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 311402, China
| | - Li Fang
- Key Laboratory of Health Risk Factors for Seafood of Zhejiang Province (Zhoushan Municipal District Center for Disease Control and Prevention), Zhoushan, 316021, China
| | - Hang-Sheng Zheng
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 311402, China.
| | - Chao-Feng Mu
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 311402, China
| | - Fan-Zhu Li
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 311402, China
| | - Yong-Sheng Zhang
- College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 311402, China
| |
Collapse
|
8
|
Schepetkin IA, Ramstead AG, Kirpotina LN, Voyich JM, Jutila MA, Quinn MT. Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed). Phytother Res 2016; 30:1287-97. [PMID: 27215200 DOI: 10.1002/ptr.5648] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2016] [Revised: 03/27/2016] [Accepted: 04/29/2016] [Indexed: 01/27/2023]
Abstract
Epilobium angustifolium is a medicinal plant used around the world in traditional medicine for the treatment of many disorders and ailments. Experimental studies have demonstrated that Epilobium extracts possess a broad range of pharmacological and therapeutic effects, including antioxidant, anti-proliferative, anti-inflammatory, antibacterial, and anti-aging properties. Flavonoids and ellagitannins, such as oenothein B, are among the compounds considered to be the primary biologically active components in Epilobium extracts. In this review, we focus on the biological properties and the potential clinical usefulness of oenothein B, flavonoids, and other polyphenols derived from E. angustifolium. Understanding the biochemical properties and therapeutic effects of polyphenols present in E. angustifolium extracts will benefit further development of therapeutic treatments from this plant. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Igor A Schepetkin
- Department of Microbiology and Immunology, Montana State University, Bozeman, MT, 59717, USA
| | - Andrew G Ramstead
- Department of Microbiology and Immunology, Montana State University, Bozeman, MT, 59717, USA
| | - Liliya N Kirpotina
- Department of Microbiology and Immunology, Montana State University, Bozeman, MT, 59717, USA
| | - Jovanka M Voyich
- Department of Microbiology and Immunology, Montana State University, Bozeman, MT, 59717, USA
| | - Mark A Jutila
- Department of Microbiology and Immunology, Montana State University, Bozeman, MT, 59717, USA
| | - Mark T Quinn
- Department of Microbiology and Immunology, Montana State University, Bozeman, MT, 59717, USA
| |
Collapse
|
9
|
Yi J, Wu JG, Wu JY, Wu YB. Quality evaluation of the leaves ofMagnolia officinalisvar.bilobausing high-performance liquid chromatography fingerprint analysis of phenolic compounds. J Sep Sci 2016; 39:784-92. [DOI: 10.1002/jssc.201500972] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2015] [Revised: 11/17/2015] [Accepted: 11/24/2015] [Indexed: 12/13/2022]
Affiliation(s)
- Jun Yi
- Department of Science; Fujian Institute of Education; Fuzhou China
| | - Jian-Guo Wu
- Academy of Integrative Medicine; Fujian University of Traditional Chinese Medicine; Fuzhou China
| | - Jin-Yu Wu
- Academy of Integrative Medicine; Fujian University of Traditional Chinese Medicine; Fuzhou China
| | - Yan-Bin Wu
- Academy of Integrative Medicine; Fujian University of Traditional Chinese Medicine; Fuzhou China
| |
Collapse
|
10
|
Zhang J, Zhao F, Yu X, Lu X, Zheng G. Pharmacokinetics of eupalinolide A, eupalinolide B and hyperoside from Eupatorium lindleyanum in rats by LC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 995-996:1-7. [DOI: 10.1016/j.jchromb.2015.04.038] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2015] [Revised: 04/20/2015] [Accepted: 04/26/2015] [Indexed: 02/08/2023]
|
11
|
Yu B, Cao Y, Xiong YK. Pharmacokinetics of aconitine-type alkaloids after oral administration of Fuzi (Aconiti Lateralis Radix Praeparata) in rats with chronic heart failure by microdialysis and ultra-high performance liquid chromatography-tandem mass spectrometry. JOURNAL OF ETHNOPHARMACOLOGY 2015; 165:173-179. [PMID: 25708163 DOI: 10.1016/j.jep.2015.01.057] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/07/2014] [Revised: 12/03/2014] [Accepted: 01/15/2015] [Indexed: 06/04/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Fuzi [the lateral root of Aconitum carmichaeli Debx (Ranunculaceae)] is a well-known traditional medicinal herb used to treat chronic heart failure (CHF). Aconitine-type alkaloids are major alkaloids that are responsible for the pharmacological activity and toxicity of this herb.To investigate therapeutic effects and pharmacokinetic profiles of aconitine-type alkaloids in CHF rats. MATERIALS AND METHODS The plasma pharmacokinetic profiles of aconitine, mesaconitine, and hypaconitine were investigated after once treatment of Fuzi extract (containing aconitine 0.086 mg/g, mesaconitine 0.84 mg/g, and hypaconitine 1.97 mg/g) using a rapid and sensitive combinative method of ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and microdialysis (MD). The cardiac function and antioxidant enzyme activities were also evaluated. RESULTS Recoveries of MD sampling ranged from 35.06% to 45.74% with RSD below 6.05%. Fuzi extract improved the myocardial function and antioxidant enzymatic activities of rats with CHF. Aconitine, mesaconitine, and hypaconitine exhibited slower absorption into the bloodstream, and yielded 11-fold less values of area under concentration-time curve (AUC) in the CHF rats than those in normal rats. The plasma AUC showed that the maximum blood concentration (Cmax) was 5.561 ng/mL for aconitine, 17.30 ng/mL for mesaconitine, and 17.78 ng/mL for hypaconitine in normal rats, while these were 0.6059 ng/mL, 2.430, and 0.7461 ng/mL in CHF rats, respectively. CONCLUSION Aconitine-type alkaloids associated with Fuzi׳s efficacy have lower intake and slower elimination in the CHF rats, indicating a non-interdependent relationship between its efficacy and toxicity. It may contribute to the depth understanding of the toxicological and pharmacological profiles of Fuzi and further benefit the herbal drug development with safety and efficacy for CHF treatment.
Collapse
Affiliation(s)
- Bing Yu
- Zhejiang Chinese Medical University, Binjiang 310053, China
| | - Yi Cao
- Zhejiang Provincial Hospital of TCM, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China
| | - Yao-Kang Xiong
- Zhejiang Chinese Medical University, Binjiang 310053, China.
| |
Collapse
|
12
|
Zhao L, Liang S, Lv L, Zhang H, guo-Tan G, Chai Y, Zhang G. Screening and analysis of metabolites in rat urine after oral administration ofApocynum venetumL. extracts using HPLC-TOF-MS. J Sep Sci 2014; 37:515-26. [PMID: 24376178 DOI: 10.1002/jssc.201301036] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2013] [Revised: 12/11/2013] [Accepted: 12/13/2013] [Indexed: 11/11/2022]
Affiliation(s)
- Liang Zhao
- Department of Pharmacy; Eastern Hepatobiliary Surgery Hospital; Shanghai China
| | - Shanshan Liang
- Department of Pharmacy; Eastern Hepatobiliary Surgery Hospital; Shanghai China
- Instrumental Analysis & Research Center; Shanghai Institute of Pharmaceutical Industry; Shanghai China
| | - Lei Lv
- Department of Pharmacy; Eastern Hepatobiliary Surgery Hospital; Shanghai China
| | - Hai Zhang
- Department of Pharmacy; Eastern Hepatobiliary Surgery Hospital; Shanghai China
| | - Guang guo-Tan
- School of Pharmacy; Second Military Medical University; Shanghai China
| | - Yifeng Chai
- School of Pharmacy; Second Military Medical University; Shanghai China
| | - Guoqing Zhang
- Department of Pharmacy; Eastern Hepatobiliary Surgery Hospital; Shanghai China
| |
Collapse
|
13
|
Zhou D, Jin Y, Yao F, Duan Z, Wang Q, Liu J. Validated LC-MS/MS method for the simultaneous determination of hyperoside and 2′′-O-galloylhyperin in rat plasma: application to a pharmacokinetic study in rats. Biomed Chromatogr 2013; 28:1057-63. [PMID: 24375731 DOI: 10.1002/bmc.3117] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2013] [Revised: 11/03/2013] [Accepted: 11/25/2013] [Indexed: 12/31/2022]
Affiliation(s)
- Donghui Zhou
- Department of Cardiology; The Fourth Affiliated Hospital of China Medical University; Shenyang 110032 Liaoning China
| | - Yuanzhe Jin
- Department of Cardiology; The Fourth Affiliated Hospital of China Medical University; Shenyang 110032 Liaoning China
| | - Fengchen Yao
- Department of Cardiology; The Fourth Affiliated Hospital of China Medical University; Shenyang 110032 Liaoning China
| | - Zhiying Duan
- Department of Cardiology; The Fourth Affiliated Hospital of China Medical University; Shenyang 110032 Liaoning China
| | - Qi Wang
- Department of Cardiology; The Fourth Affiliated Hospital of China Medical University; Shenyang 110032 Liaoning China
| | - Jing Liu
- Department of Cardiology; The Fourth Affiliated Hospital of China Medical University; Shenyang 110032 Liaoning China
| |
Collapse
|